Technical Analysis for IBO - Impact BioMedical, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | N/A | N/A | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Doji - Bearish? | Reversal | 0.00% | |
| NR7 | Range Contraction | 5.31% | |
| Narrow Range Bar | Range Contraction | 5.31% | |
| Gapped Up | Strength | 4.89% | |
| Hot IPO Pullback | Bullish Swing Setup | 17.41% | |
| New 52 Week Low | Weakness | 17.41% | |
| New 52 Week Closing Low | Bearish | 23.87% | |
| Hot IPO Pullback | Bullish Swing Setup | 23.87% | |
| New 52 Week Low | Weakness | 23.87% | |
| Down 3 Days in a Row | Weakness | 23.87% |
| Alert | Time |
|---|---|
| Outside Day | about 17 hours ago |
| Fell Below Previous Day's Low | about 17 hours ago |
| Rose Above Previous Day's High | about 19 hours ago |
| Down 3% | about 19 hours ago |
| Up 5% | about 19 hours ago |
Get this analysis on your stocks daily!
- Earnings date: Unknown
Impact BioMedical, Inc. Description
Impact BioMedical Inc. engages in the discovery and development of products and treatment options in specialty biopharmaceuticals and consumer healthcare. It provides Linebacker, a platform of small molecule electrophilically enhanced polyphenol compounds with application in oncology, inflammatory disorders, and neurology; and Laetose technology that is derived from a unique combination of sugar and inositol, which can inhibit the inflammatory and metabolic response of sugar alone. The company also develops functional fragrance formulation, a suite of functional fragrances containing specialized botanical ingredients with application as an antimicrobial, and as an additive in insect repellents, detergents, lotions, shampoo, fabrics, and other substances. In addition, it develops Equivir/Equivir G technology, a novel blend of polyphenols, which have demonstrated antiviral effects for use in as health supplements and medications. The company was incorporated in 2018 and is based in Houston, Texas.
Classification
Sector: Healthcare
Industry: Biotechnology
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 3.0 |
| 52 Week Low | 1.23 |
| Average Volume | 148,507 |
| 200-Day Moving Average | 0.00 |
| 50-Day Moving Average | 0.00 |
| 20-Day Moving Average | 0.00 |
| 10-Day Moving Average | 1.65 |
| Average True Range | 0.30 |
| RSI (14) | 34.64 |
| ADX | 0.0 |
| +DI | 16.66 |
| -DI | 31.94 |
| Chandelier Exit (Long, 3 ATRs) | 2.09 |
| Chandelier Exit (Short, 3 ATRs) | 2.14 |
| Upper Bollinger Bands | 0.00 |
| Lower Bollinger Band | 0.00 |
| Percent B (%b) | 0.0 |
| BandWidth | 0.00 |
| MACD Line | -0.28 |
| MACD Signal Line | -0.18 |
| MACD Histogram | -0.0975 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 1.84 | ||||
| Resistance 3 (R3) | 1.82 | 1.72 | 1.80 | ||
| Resistance 2 (R2) | 1.72 | 1.65 | 1.73 | 1.78 | |
| Resistance 1 (R1) | 1.65 | 1.61 | 1.68 | 1.66 | 1.77 |
| Pivot Point | 1.54 | 1.54 | 1.56 | 1.55 | 1.54 |
| Support 1 (S1) | 1.47 | 1.47 | 1.50 | 1.48 | 1.38 |
| Support 2 (S2) | 1.36 | 1.43 | 1.37 | 1.36 | |
| Support 3 (S3) | 1.29 | 1.36 | 1.35 | ||
| Support 4 (S4) | 1.30 |
